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Introduction: The aim of the study was to identify the dependency structure of genetic variants that can influence
the outcome for paediatric patients with sepsis.
Methods: We evaluated the role of single nucleotide polymorphisms for five genes: bactericidal permeability
increasing protein (BPI; rs5743507), lipopolysaccharide-binding protein (LBP; rs2232618), toll-like receptor 4
(TLR4; rs4986790), heat shock protein 70 (HSP 70; rs2227956), and interleukin 6 (IL-6; rs1800795) in 598 children aged 0
to 19 years that were admitted to a paediatric intensive care unit with fever, systemic inflammatory response syndrome,
sepsis, severe sepsis, septic shock, or multiple organ dysfunction syndrome. A control group of 529 healthy individuals
was included. Multi-way contingency tables were constructed and statistically evaluated using log-linear models. Typical
gene combinations were found for both study groups.
Results: Detailed analyses of the five studied gene profiles revealed significant differences in sepsis survival. Stratification
into high-risk, intermediate-risk, and low-risk groups of paediatric patients can predict the severity of sepsis.
Conclusions: Analysis of single nucleotide polymorphisms for five genes can be used as a predictor of sepsis outcome
in children.Introduction
Sepsis remains one of the most threatening conditions in
intensive care units [1,2]. It is defined as the systemic
inflammatory response of the human host that is triggered
by an invading pathogen (bacterial, viral, fungal, parasitic or
combined). Despite outstanding achievements in research
and clinical practice, sepsis remains among the major causes
of morbidity and mortality worldwide [3,4]. Hitherto, only
limited data on this condition have been available from
children. A population-based epidemiologic study estimated
that in 2003 a total of about 300,000 infectious disease hos-
pitalizations occurred among infants (less than one year of
age) in the United States alone and accounted for 42.8% of
all infant hospitalizations [5]. Septic states remain one of the* Correspondence: jmichalek@fnbrno.cz
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distribution, and reproduction in any mediummost common causes of neonatal morbidity and mortality,
especially in the preterm population [6]. The high incidence,
associated costs and mortality rate of patients with sepsis
has in recent decades led the critical care scientific commu-
nity to develop specific strategies aimed at improving the
outcome of septic states [7,8]. Nevertheless, sepsis mortality
has not decreased dramatically during the past decade [4].
Patients admitted to intensive care units with general
conditions that seemingly correspond to the severity of
infection may nevertheless present fundamentally different
survival rates. We hypothesize that at least part of this
variability in the sepsis outcome may be due to variation
in genes coding components of the innate immune
response. Individual differences in disease manifestation
influenced by the genetic predisposition have been
recognized by the PIRO concept that stratifies patients
with sepsis on the basis of their Predisposing conditions,
the nature and extent of the Insult (infection or trauma),
the nature and magnitude of the host Response, and the
degree of concomitant Organ dysfunction [9]. The P, Rtral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Jabandziev et al. Critical Care 2014, 18:R1 Page 2 of 9
http://ccforum.com/content/18/1/R1and O components of the PIRO concept depend largely
on the genetic predisposition of the individual patient.
Gene variants (mainly single nucleotide polymorphisms
(SNPs)) in genes related to inflammatory and immune
system regulations may explain, at least to some extent,
the variability of clinical course observed in sepsis and
infections. Most previous studies related to SNPs in
sepsis were performed on adults [10]. Our group focuses
on the paediatric population and previously demonstrated
that interleukin 6 (IL-6) and bactericidal permeability
increasing protein (BPI) polymorphisms are associated
with different outcomes of sepsis [11,12]. We recently have
focused on multiparametric analyses of five polymorphisms
in five genes that play critical roles in or are associated with
inflammatory response, sepsis severity and mortality in
order to identify possible predictive mechanisms for sepsis
risk stratification. The following genes and their SNPs
were investigated: 1) toll-like receptor 4 (TLR, OMIM
acc. No. 603030) (rs4986790), which is a part of the
lipopolysaccharides (LPS) recognition/response unit [13];
2) lipopolysaccharide-binding protein (LBP, OMIM acc.
No. 151990) (rs2232618), which is a soluble acute phase
protein that binds to LPS of Gram-negative bacteria
and facilitates the transfer of bacterial LPS to the specific
receptor CD14 [14]; 3) bactericidal permeability increasing
protein (BPI, OMIM acc. No. 109195) (rs5743507), which
displays activity against a wide range of Gram-negative
bacteria, reflecting high affinity to lipid A of the LPS
regions and potent endotoxin-neutralizing activity [12,15];
and 4) interleukin 6 (IL-6, OMIM acc. No. 147620)
(rs1800795), which is a key proinflammatory cytokine
and plays an important role in the development,
pathogenesis and outcome of systemic inflammatory
response syndrome, sepsis and septic shock [11]. Plasma
levels of IL-6 are elevated in patients with sepsis and
high IL-6 concentrations are associated with increased
mortality [16,17]. Genetic variation within the regulatory
part of the IL-6 gene may affect the incidence and outcome
of sepsis [10,11]. Finally, the role of heat shock protein
A1L (HSP 70, OMIM acc. No. 140560) (rs2227956),
which helps to protect cells from thermal or oxidative
stress [18,19], was investigated. While several studies
have revealed the importance of genetic polymorphisms
in the course and outcome of sepsis [10,20], only a few
[21] have demonstrated the influence of combinations
of genetic polymorphisms, even though the genetic pre-
disposition to sepsis is polygenic and with many variants
in multiple gene loci playing different roles. Only limited
data are available from the paediatric sepsis population
regarding genetic polymorphism studies and their role in
sepsis severity prediction. To our knowledge, no multiple
gene SNPs analysis has been performed to demonstrate
predictability in paediatric patients with sepsis. This study
presents data based on multiparametric analyses of fiveSNPs of immune-related and inflammation-related genes
that are involved in the immune response in sepsis.
Materials and methods
A total of 598 paediatric patients aged 0 to 19 years (325
males, 273 females) were enrolled if they met the following
inclusion criteria: 1) admission to the Paediatric Intensive
Care Unit (PICU) at University Hospital Brno for at least
24 h; 2) fever (defined as body temperature above 39°C or
above 38.5°C measured consecutively at two occasions at
least 6 h apart), systemic inflammatory response syndrome,
sepsis, severe sepsis, septic shock or multiple organ
dysfunction syndrome (MODS) based on generally accepted
consensus criteria published and modified for paediatric
patients by the American College of Chest Physicians and
the Society of Critical Care Medicine [22,23]; 3) signed
informed consent by their parents or legal guardians; and
4) successful genotyping of all studied gene variants.
Patients were enrolled from September 2003 to December
2009, their clinical status was monitored on a daily basis,
and the outcome of the stay at the PICU was carefully
evaluated. Patients hereinafter referred to as non-survivors
died as a direct consequence of the septic event.
As a control group, 529 healthy individuals (269 male
and 260 female) aged 26 to 67 years were analysed after
signing a written informed consent. This group represents
a random sample of the population of two districts of the
Czech Republic selected according to the World Health
Organization protocol (Multinational monitoring of trends
and determinants in cardiovascular diseases (the MON-
ICA Project)). This study hereinafter refers to patients
generally as the patient group (PG), patients with severe
sepsis, septic shock, or MODS as the patient group with
severe condition (PGS), and healthy controls as the
control group (CG).
This study was approved by the Institutional Review
Board of the University Hospital Brno in accordance with
the 1964 Declaration of Helsinki.
Genetic analysis
DNA was isolated according to the standard protocol
from EDTA blood as previously described [24]. DNA
variants of the genes studied (that is, BPI, LBP, TLR, HSP
70 and IL-6) were analysed using PCR and restriction
analyses. For more details about the oligonucleotide
sequences, restriction enzyme used and detailed PCR
conditions, see the authors’ previous work [11,12] or
contact the corresponding author.
Statistical methods
The statistical theory of log-linear models and logit analysis
for the evaluation of multi-way contingency tables was used
[25], including the theory of graphical models [26]. The
adequate log-linear graphical model was chosen by stepwise
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(StatSoft Inc., Tulsa, OK, USA) and likelihood ratio statistics
G2. The U statistics based on arcsine transformation [28]
and Fisher’s exact test with mid-P-value [25] were used to
compare the equality of two independent binomial popula-
tions (frequencies) for small sample sizes. The theory of
generalized linear models [25] was used to classify the com-
binations of risk SNP variants into groups according to the
level of risk and to calculate probabilities for the risk groups.
The software STATISTICA (version 10.0.1011.0) and
MATLAB software manufacturer: (MathWorks Inc., Natick,
MA, USA) (version 7.11.0.584) were used for computing.
Statistical analysis
Descriptive statistics were used for basic characterization
of both PG and CG. Individual genotypes were distin-
guished and labelled as follows: major/common homozy-
gote (aa), heterozygote (ab) and minor allele homozygote
(bb). Some genotype frequencies in group (bb) were very
small, including only three or fewer subjects. For this
reason, it was necessary to re-code the gene variants to
meet the requirements of the statistical tests and enable
reliable evaluation of information from the data sets.
Thus, genotypes of all studied genes were coded and
labelled according to the following key: common, major
homozygotes (aa) were labelled (A) and those remaining
(that is, heterozygotes (ab) and minor homozygotes (bb))
were collapsed and labelled (B). Absolute and relative
frequencies were determined for the occurrence of variant
A of the respective gene in PG, PGS and CG.
Further analyses were based on comparisons of relative
frequencies between PG and CG or between PGS and CG.
These comparisons were performed not only for individual
SNPs of each gene, but also for the combinations of two,
three, four and five genes. Initially, two five-way contin-
gency tables (for each PG and CG) were created. Each table
was formatted as 2 × 2 × 2 × 2 × 2 for the five SNPs stud-
ied. These contingency tables were then analysed using log-
linear models for five dimensions, the optimal graphical
model for both groups was found, and comparisons of
groups were made using Fisher’s exact test and mid-P-value
as well as by the test using U statistics for comparing two
independent binomial frequencies. Two different statistics
were used to compare the adequacy of the chosen tests in
cases of small frequencies. When both tests yielded the
same results, only results based on Fisher’s exact test are
reported. An identical approach was then applied for
comparisons between PGS and CG.
Based on results of previous comparisons, the theory
of generalized linear models was used and the SNP
combinations were classified according to the value of
the probability that the given SNP combination would
appear in PG or CG. The SNP combination risk groups
could be determined using this method. If the results ofall methods are consistent, typical SNP variants associated




Most of the patients were admitted to the PICU due to
infection (181 patients with respiratory tract infection
(30.3%), 60 with urogenital infection (10%), 73 with central
nervous system infection (12.2%), 56 with abdominal
infection (9.4%) and 49 with other infections (8.2%)).
The remaining 179 (29.9%) were admitted due to trauma
or some other surgical condition. Overall survival was
575 (96.2%) out of 598 patients enrolled. All patients
experiencing only a febrile episode (131 patients) or
systemic inflammatory response syndrome (314 patients)
survived. As expected, the mortality rate was low in the
sepsis subgroup (2.6%, that is, 1 out of 39 patients), higher
in the severe sepsis subgroup (5.5%, that is, 4 out of 73
patients), and highest in the septic shock and MODS
subgroup (43.9%, that is, 18 out of 41 patients). Detailed
characteristics of non-survivors are summarized in Table 1.
The presence of an infection either upon admission or
that developed during the stay at the PICU was confirmed
in 297 (49.7%) of 598 paediatric patients. The cause of
infection was Gram-positive bacteria in 123 cases (41.4%),
Gram-negative bacteria in 112 cases (37.7%), viruses in 37
cases (12.5%) and fungi or other infectious agents in 25
cases (8.4%).
Single nucleotide polymorphisms
The complete genotyping was successful in 598 patients
and in 529 control individuals. No age or gender differences
have been demonstrated in the distribution of gene variants
in either PG or CG. The distributions of individual geno-
types of both polymorphisms are in Hardy-Weinberg equi-
librium in both groups. The genotype relative frequencies
in PG and CG are shown in Figure 1 and Table 2.
To describe interactions among the five genes studied,
the adequate statistical association structures of SNPs
in both PG and CG were determined using optimal
association graphs. Associations are demonstrated in
Figure 2. Both graphs were constructed to reveal the most
typical statistical associations among the SNPs studied.
The differences between PG and CG are demonstrated at
Figure 1, Figure 2 and Table 2. For PG, the association
among BPI, TLR and LBP is typical and there is a three-
factor interaction. This means that each pair of these three
variables may be conditionally dependent and an odds
ratio for any pair of these three variables may vary across
levels of the third variable. In addition, IL-6 is condition-
ally independent from BPI and LBP provided that the
presence of the TLR SNP is fixed, whereas the occurrence
of the HSP 70 SNP is independent of the preceding four
Table 1 Clinical and SNP characteristics of non-survivors
Original diagnosis Cause of death Causative pathogen BPI LBP TLR HSP 70 IL-6 Risk variants of five genes
Crohn’s disease Septic shock CMV, Candida A A A B A H
Pneumonia Septic shock Not identified A A A B A H
Peritonitis Septic shock Not identified A A A A B H
Pneumonia Severe sepsis G + bacteria A B A A B I
Pneumonia Septic shock Not identified A A A A B H
Pneumonia Septic shock Not identified A B A A A H
Pneumonia Septic shock G- bacteria A A A A B H
Pneumonia Severe sepsis G + bacteria A B A B B I
Multiple injury Septic shock G + bacteria A A A A B H
Pneumonia Septic shock Not identified A A A B A H
Pneumonia Severe sepsis G- bacteria A A A B A H
Pneumonia Septic shock Not identified A A A A A I
Ileus Septic shock G + bacteria A A A A B H
Multiple injury Sepsis Not identified A A A A B H
Pneumonia Severe sepsis Not identified B A A B B I
Cranial injury Septic shock G + bacteria A A A A B H
Pneumonia Septic shock Aspergillus A B A B B I
Meningitis Septic shock Not identified B A B A A I
Pulm. embolism Septic shock Actinomyces A A A A B H
Pneumonia Septic shock G + bacteria A A B A A I
Pneumonia Septic shock Candida A B B A B I
Ileus Septic shock G- bacteria A B A A B I
Gastroenteritis MODS G- bacteria A A A A B H
A, common (wild-type) homozygotes (aa); B, heterozygotes (ab) and minor homozygotes (bb); H, high-risk sepsis combination of five single nucleotide polymorphism
(SNP) variants; I, intermediate risk sepsis combination of five SNP variants.
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HSP 70, HSP 70 and LBP, and LBP and IL-6. The TLR
SNP is independent from the other four SNPs. The graphs
in Figure 2 were used in further searching for high-risk
and low-risk variants of SNP combinations.Figure 1 Relative frequencies of wild-type homozygote variants. Relat
genes in the control group (CG), group of patients (PG) and group of patie
organ dysfunction syndrome (MODS) (patient group with severe conditionIn view of Figure 2, detailed comparison was made
between the frequencies of the following three SNP
combinations: 1) BPI, LBP and TLR; 2) BPI, TLR and
IL-6; and 3) LBP, TLR and IL-6. Binomial testing based
on U statistics and Fisher’s exact test was used. Theive frequencies of the occurrence of major homozygotes for the given
nts with highly serious sepsis - severe sepsis, septic shock and multiple
, PGS).
Table 2 Wild type homozygote frequencies
Gene CG (n = 529) PG (n = 598) PGS (n = 114)
abs. rel. abs. rel. abs. rel.
BPI 333 0.629 450 0.753 92 0.807
LBP 432 0.817 480 0.803 85 0.746
TLR 466 0.881 531 0.888 105 0.921
HSP 70 355 0.671 420 0.702 74 0.649
IL-6 124 0.234 194 0.324 41 0.360
Absolute (abs.) and relative (rel.) frequencies of the occurrence of major
homozygotes for the given genes in the control group (CG), group of patients
(PG), and group of patients with highly serious sepsis - severe sepsis, septic
shock and multiple organ dysfunction syndrome (MODS) (patient group with
severe condition, PGS).
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demonstrated significant differences, and the findings
of the two statistical tests were in good agreement.
Therefore, only the results of Fisher’s exact test are
reported in Table 2. Table 2 also demonstrates risk
prediction in unrelated BPI and HSP 70 SNPs as well
as non-associated combination of BPI and HSP 70 and
combination of all five examined SNPs. Based on these
results, we can clearly identify high, intermediate and
low sepsis risk populations in paediatric patients.
Detailed statistical analysis of a unique BPI, LBP and
TLR gene triplet detected significant differences in
genetic structure between the studied groups. The high-
risk combination associated with sepsis development
was BPI A + LBP A +TLR A. The proportion of combined
major homozygotes was significantly higher in PG
compared to CG (P = 0.005). The comparison between
the PGS and the CG revealed BPI A + LBP B + TLR A as
a high-risk combination (P = 0.034). On the contrary, a
low-risk sepsis development combination was BPI B + LBP
A + TLR A for both PG and PGS in comparison with
CG (P <0.001; P = 0.003, respectively). Similar to the
previous triplet, the combination of major homozygosityA
Figure 2 Optimal graphical models of genetic interconnections. Optim
nucleotide polymorphisms (SNPs) in patients and healthy controls. A) Mod
group of patients (PG). B) Model mapping the most typical associations befor BPI, TLR and IL-6 SNPs was associated with high
risk of sepsis development (P <0.001). Furthermore, this
association was even more expressed in PGS (P = 0.003).
In contrast, the combination of BPI B + TLR A + IL-6 B
represents low risk for PG and PGS (P <0.001; P = 0.001,
respectively).
Analyses of the specific triplet LBP, TLR and IL-6 showed
LBP A + TLR B + IL-6 A and LBP B + TLR A + IL-6 A
combinations (P = 0.006; P = 0.012, respectively) to be
at high risk for sepsis development, but occurrence of
the proposed variants was low (4.2 and 4.8% of patients).
A low-risk variant for PGS was the LBP A +TLR A + IL-6
B combination (P = 0.027), which was the most common
variant in this group (41.2% of patients).
A non-associated combination of wild-type homozygote
variants of BPI and HSP 70 genes together represented
high risk for sepsis development (P < 0.001), and this was
statistically significant for PGS (P = 0.004). The combin-
ation BPI B +HSP 70 A for the sepsis group (P <0.001)
and for PGS (P <0.001) represented low risk.
This highly complex analysis of the five studied genes’
distribution showed significant differences between patients
and control groups. A high-risk combination for sepsis
development and typical for the patients group was the
quintet of wild-type homozygotes (P = 0.005), but the most
common specific combination in the three studied groups
was BPI A + LBP A + TLR A +HSP 70 A + IL-6 B. This
combination also represented high risk for sepsis devel-
opment (P = 0.016). A low-risk variant was BPI B + LBP
A+TLR A+HSP 70 A+ IL-6 B both in patients (P= 0.006)
and PGS (P= 0.001). Frequencies of other low-risk variants
BPI B + LBP A+TLR B+HSP 70 A+ IL-6 B and BPI B +
LBP B + TLR A + HSP 70 A + IL-6 B differ significantly
between the groups (for details, see Table 3).
These data are in agreement with results of the other
statistical method, the generalized linear model (optimal
logit model). These models calculated the probabilitiesB
al association graphs describing relations among five single
el mapping the most typical associations between genes studied in
tween genes studied in control group (CG).
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to CG or PG. The logit model then enables setting 95%
confidence intervals for these probabilities. The results
of these analyses confirmed that all combinations forTable 3 Evaluation of sepsis risk based on five SNPs in paedia
Contro
group (n =
Genes SNP* variant No. (%
Associated SNP
combinations
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Single nucleotide polymorphisms’ (SNPs’) frequencies and their sepsis risk evaluatio
SNP variants indicate the wild-type (most frequent) homozygote with label “A”, whi
stated in the same order as genes.high-risk and low-risk cases shown in Table 3 are
adequate (see the Additional file 1 for further details).
Finally, in the group of patients with severe condition,




group (n = 598)
Patient group with
severe condition (n = 114)
) No. (%) Fisher
Mid-P
Risk No. (%) Fisher
Mid-P
Risk
.5 319 53.3 0.005 H 62 54.4 0.071 I
9 34 5.7 0.950 I 4 3.5 0.236 I
.0 87 14.5 0.068 I 23 20.2 0.034 H
3 10 1.7 0.721 I 3 2.6 0.308 I
.8 110 18.4 <0.001 L 17 14.9 0.003 L
8 17 2.8 0.361 I 2 1.8 0.224 I
1 15 2.5 0.022 L 3 2.6 0.198 I
9 6 1.0 0.882 I 0 0 0.188 I
.0 127 21.2 <0.001 H 31 27.2 0.003 H
.7 279 46.7 0.177 I 54 47.4 0.378 I
3 21 3.5 0.016 H 1 0.9 0.818 I
9 23 3.8 0.109 I 6 5.3 0.745 I
3 36 6.0 0.148 I 7 6.1 0.398 I
.0 89 14.9 <0.001 L 13 11.4 0.001 L
8 10 1.7 0.146 I 2 1.8 0.489 I
0 13 2.8 0.100 I 0 0 0.008 L
.3 134 22.4 0.200 I 32 28.1 0.050 I
.7 295 49.3 0.245 I 47 41.2 0.027 L
5 25 4.2 0.006 H 3 2.6 0.602 I
1 26 4.3 0.011 L 3 2.6 0.015 L
1 29 4.8 0.012 H 6 5.3 0.206 I
.0 73 12.2 0.401 I 20 17.5 0.345 I
6 6 1.0 0.416 I 0 0 0.278 I
7 10 1.7 0.909 I 3 2.6 0.596 I
.1 323 54.0 <0.001 H 63 55.3 0.004 H
.9 127 21.2 0.494 I 29 25.4 0.585 I
.0 97 16.2 <0.001 L 11 9.6 <0.001 L
.0 51 8.5 0.382 I 11 9.6 0.932 I
8 70 11.7 0.005 H 13 11.4 0.157 I
.0 162 27.1 0.016 H 29 25.4 0.354 I
6 3 0.5 0.004 L 1 0.9 0.172 I
1 22 3.7 0.005 H 5 4.4 0.133 I
.2 48 8.0 0.006 L 4 3.5 0.001 L
8 7 1.2 0.041 L 0 0 0.026 L
8 8 1.3 0.009 L 2 1.8 0.224 I
.6 278 46.5 0.492 I 60 52.6 0.440 I
n for three sets of associated genes, non-associated genes and five gene SNPs.
le heterozygote or minor homozygotes are shown as “B”. SNP variants are
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Due to limited numbers in each subgroup, the power of
the tests used is low and the data demonstrate only
trends or statistical significance at the 10% level (Table 4).
The one-side and two-side alternatives were considered.
The distribution showed no differences in any patient
group when compared to the control group. However,
specific combinations indicated a tendency to be over-
represented in the non-survivors group, such as BPI major
homozygotes (P = 0.077), combination of TLR B and IL-6
A (P = 0.055), combination of LBP A + TLR B + IL-6 A
(P = 0.055) and BPI A + LBP A+TLR A+HSP 70 A + IL-6
B (P = 0.055).
Discussion
The immune response in sepsis is an extremely multifa-
ceted cascade of events involving inflammatory and anti-
inflammatory processes, humoral and cellular reactions,
and circulatory abnormalities [29]. Several risk factors
for sepsis development have been identified [30], but
the cause of basic differences in susceptibility between
individuals and populations remains unclear.
Host genetic variability in the regulatory and coding
regions of genes for components of the innate immune
system, inflammatory cytokines and coagulation cascade
may influence the susceptibility to and/or outcome from
sepsis. SNPs can result in absolute deficiency of a protein,
an altered protein, a change in the level of normal protein
expression, or no discernible change in protein function
or expression, and they are thought to explain at least
in part the interindividual differences in susceptibility [30].
In recent years, many investigators have observed
potential associations between immune-related gene
polymorphisms and the development, course and out-
come of septic episodes - and often with apparently
conflicting results [10,20]. Differences in study design,Table 4 Risk of death in patients with severe condition
Genes SNP variant Survivors (n = 91) Non
No. (%) No
BPI A 71 78.0 21
BPI B 20 22.0 2
BPI; TLR BA 19 20.9 1
TLR; IL-6 BA 1 1.1 2
BPI; LBP; TLR BAA 16 17.6 1
BPI; TLR; IL-6 BAA 7 7.7 0
LBP; TLR; IL-6 ABA 1 1.1 2
BPI; LBP; TLR; HSP 70; IL-6 AAAAB 20 22.0 9
AAABB 8 8.8 0
All single nucleotide polymorphism (SNP) combinations revealing at least 10% leve
septic shock or multiple organ dysfunction syndromes (MODS) (based on two-sided
statistically significant differences and are not presented.ethnicity, as well as gene-to-gene and gene-to-environmen-
tal interactions could be limiting factors. The outcome
of a septic condition is influenced by multiple host and
pathogen factors, including the patient’s age, gender and
race, as well as the presence of comorbid conditions, the
patient’s underlying immune status, and the specific
pathogen involved [31]. It is clear that only a part of
the genetic contribution to sepsis development may be
explained by the identified gene polymorphisms.
Differences in environmental exposures and genetic
heterogeneity between ethnic groups may have compli-
cated the search for genetic and gene-environmental
determinants. The contributions of gene-gene interaction
to the risk of diseases have been documented (for example,
in the case of breast cancer) [32,33]. Data from populations
with sepsis are poor and, moreover, developmental differ-
ences that affect the haemodynamic, inflammatory, coagula-
tion and immune responses make it difficult to extrapolate
data from adult studies to paediatric populations [31].
This study evaluates combined genetic polymorphisms
for their possible association with susceptibility to septic
conditions and outcome of all septic episodes. To the
best of our knowledge, we have evaluated for the first time
in a Central European population of critically ill children
the influence of genetic polymorphism interactions of
five genes related to immune response. The results demon-
strate that the specific combinations of genetic polymor-
phisms seem to be associated with sepsis development. We
believe that we can conclude this, despite the fact that we
have used healthy adults as controls. There is no evidence
that allelic frequencies in some genes are significantly
different in children and in adults.
The study points out the importance of interactions
among the BPI, LBP, TLR, HSP 70 and IL-6 polymor-
phisms and also highlights the relevance of the combin-
ation of gene polymorphisms to sepsis outcome. Specific-survivors (n = 23) P (one) P (both) Risk of death
SNP variant. (%)
91.3 0.077 0.088 Risk
8.7 0.077 0.088 Non-risk
4.3 0.029 0.029 Non-risk
8.7 0.055 0.56 Risk
4.3 0.056 0.062 Non-risk
0 0.098 0.098 Non-risk
8.7 0.055 0.56 Risk
39.1 0.055 0.155 Risk
0 0.077 0.077 Non-risk
l of statistical significance between survivors and non-survivors of severe sepsis,
Fisher’s exact test) are shown. Other SNP combinations did not demonstrate
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TLR, HSP 70 and IL-6 variants were typical within the
septic group and were associated with a high risk of
sepsis development. Generally, in the group of children
with sepsis studied, individuals carrying wild-type alleles
of the proposed genes in various combinations had
increased risk for sepsis development compared to those
with the minor alleles. Similar to our findings, a study
by Flores et al. [34] had concluded that a common SNP
risk haplotype of LBP was strongly associated with sus-
ceptibility to severe sepsis and homozygous carriers of
the risk haplotype had increased risk for severe sepsis.
Benermo et al. revealed that the G allele of 174 G>C
SNP in the promoter region of the IL-6 gene is functional
in vivo with increased inflammatory response [35]. This
result could be consistent with the fact that early increased
and uncontrolled release of cytokines (known as a cyto-
kine storm) and proinflammatory mediators are peculiar
for sepsis development and associated with increased
mortality [16,17].
Our data indicate that specific combinations of gene
polymorphisms - most frequently wild-type homozygote
variants - were significantly associated with sepsis develop-
ment in a large cohort of paediatric patients. In addition,
we revealed significant associations between genetic
structure in patients with severe septic conditions (severe
sepsis, septic shock and MODS). Moreover, low-risk
variants, typical for the control group and representing
low risk for sepsis development were also described. Our
hypothesis arising from our previous genetic observations
states that mutated variants of gene polymorphisms seem
to be protective against sepsis development. The exact
protective mechanism is unknown due to an incomplete
understanding of the complex pathophysiologic nature of
sepsis development. Compared to non-carriers, however,
volunteers with the mutated TLR 299 allele have been
shown to have lower concentrations of some of the in-
flammatory cytokines, acute-phase reactants and other
mediators of inflammation relatively late after the onset
of experimental endotoxemia [36].
Conclusions
Future genome-wide expression profiling studies will allow
researchers to reveal specific interactions between polymor-
phisms in genes involved in innate immunity and to stratify
patients according to their risk for certain outcomes.
The first reported genome-wide comparison of expression
patterns among healthy children and children with septic
shock revealed more than 2,000 genes that were differ-
entially expressed or repressed in patients experiencing
septic shock relative to healthy controls [37]. It is only
a question of time before a reasonable number of risky
combinations for sepsis development and for poor out-
comes can be determined [30]. High-risk patients couldbenefit from being so identified through early introduction
of specific preventive or therapeutic interventions.
These data demonstrate that such an approach can
clearly identify SNP variants that are associated with
favourable and unfavourable sepsis outcomes.
Key messages
 Five single nucleotide polymorphisms of genes
involved in inflammation can stratify paediatric
patients for risk of sepsis survival.
 Stratification into high-, intermediate- and low-risk
groups of paediatric patients can predict the severity
of sepsis.
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